Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03905720 · ClinicalTrials.gov registry record · NA
Pragmatic Research of Acupuncture and Counseling eXtended to Inpatient Services
A NA study of Pain and Malignant Solid Tumor, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 448
- Enrollment target
- 2
- Study locations
NCT03905720: Completed NA study of Pain and Malignant Solid Tumor, sponsored by University of California, San Francisco.
NCT03905720 is a NA study of Pain and Malignant Solid Tumor that has completed, run by University of California, San Francisco. The registered enrollment target is 448 participants, above the 303-participant average among 374 other Pain trials with a reported enrollment target (48% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03905720, a NA study of Pain and Malignant Solid Tumor, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 448 participants
- Enrollment target
- 2
- Study locations
Study Summary
Despite improved assessment and pharmacologic management, cancer pain is still undertreated. Using non-pharmacologic treatments alongside medications may better address patients' total pain experience by relieving physical and psychological symptoms and reducing the adverse effects of drugs. However, our knowledge of the benefits of multidisciplinary approaches in real-world hospital settings is limited. Patients want to know "How can I get the most pain relief with the fewest side effects?" This study proposal is designed to address this question by testing how combining pharmacologic and non-pharmacologic (acupuncture and pain counseling) treatments can: (1) maximize effectiveness, (2) minimize harms, and (3) align with patients' preferences.
Primary Outcome
Participants' worst level of pain in the past 24 hours on a 0-10 numeric rating scale (NRS), 0= no pain and 10= worst pain imaginable
Conditions Studied
Interventions
- PROCEDURE Acupuncture
- BEHAVIORAL Pain Counseling
Study Locations (2)
California
- Zuckerberg San Francisco General Hospital - San Francisco
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 448 participants |
| Start Date | 2019-01-17 |
| Est. Completion | 2021-09-30 |
| Phase | NA |
What the finished NCT03905720 record still lists
NCT03905720 is an interventional study that assigns participants to a tested intervention. The registered 448 participants enrollment target is mid-sized for trials with a published cap, above the 303-participant average among 374 other Pain trials with a reported enrollment target (48% higher).
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Acupuncture is the first listed.
NCT03905720 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03905720 about?
NCT03905720 is a clinical study titled "Pragmatic Research of Acupuncture and Counseling eXtended to Inpatient Services". Despite improved assessment and pharmacologic management, cancer pain is still undertreated. Using non-pharmacologic treatments alongside medications may better address patients' total pain experience by relieving physical and psychological symptoms and reducing the adverse effects of drugs. However...
What is the current status of trial NCT03905720?
This trial is currently completed. It is a NA study. The enrollment target is 448 participants. The study started on 2019-01-17. Estimated completion is 2021-09-30.
What conditions does trial NCT03905720 study?
This clinical trial studies the following conditions: Pain, Malignant Solid Tumor.
What interventions are being tested in trial NCT03905720?
The interventions under investigation include: Acupuncture (PROCEDURE), Pain Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT03905720?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03905720 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03905720's enrollment target sits among peer trials
448 43rd of 374 higher than 332 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06702449 · 448 participants · Phase 1
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
- NCT07125053 · 448 participants · NA
COPD Resources, Education, and Activity Designed for You Study
- NCT04065399 · 447 participants · Phase 1
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI